Vaccination in Special Populations Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Vaccination in Special Populations. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Vaccination in Special Populations Indian Medical PG Question 1: A girl child has had recurrent yeast and respiratory viral infections since she was 3 months old. Considering studies for her immune status, which of the following vaccines is contraindicated?
- A. Killed IPV (Inactivated Poliovirus Vaccine)
- B. DPT (Diphtheria, Pertussis, Tetanus)
- C. TT/Td (Tetanus toxoid)
- D. Measles/MMR (Correct Answer)
- E. Hepatitis B vaccine
Vaccination in Special Populations Explanation: ***Measles/MMR***
- This patient's history of **recurrent yeast and respiratory viral infections** suggests a potential **immunodeficiency**, which is a contraindication for **live attenuated vaccines** like MMR (Measles, Mumps, Rubella).
- Administering live attenuated vaccines to immunocompromised individuals can lead to **uncontrolled replication of the vaccine virus**, causing severe disease.
*Killed IPV (Inactivated Poliovirus Vaccine)*
- **Inactivated vaccines** do not contain live viruses and are generally safe for immunocompromised individuals.
- The patient's underlying immune status does not contraindicate killed vaccines, as there is **no risk of vaccine-induced infection**.
*DPT (Diphtheria, Pertussis, Tetanus)*
- DPT is a **non-live vaccine** (consisting of toxoids and inactivated bacterial components), making it safe for individuals with immunodeficiency.
- These vaccines do not pose a risk of causing the disease in immunocompromised patients, even if their **immune response is suboptimal**.
*TT/Td (Tetanus toxoid)*
- Tetanus toxoid vaccines are **inactivated vaccines** and are therefore safe for individuals with impaired immune function.
- The concern with immunodeficiency is the **ability to mount an effective immune response**, not the safety of the vaccine itself.
*Hepatitis B vaccine*
- Hepatitis B is a **recombinant inactivated vaccine** that is safe for immunocompromised patients.
- While the vaccine may have **reduced immunogenicity** in this population, it is not contraindicated and does not pose a risk of vaccine-induced disease.
Vaccination in Special Populations Indian Medical PG Question 2: In a 10-year-old school child under the school health program, which vaccine should be administered?
- A. DPT
- B. BCG
- C. Td (Correct Answer)
- D. MMR
Vaccination in Special Populations Explanation: ***Td (Tetanus-Diphtheria)***
- For a 10-year-old child under the school health program in India, the recommended vaccination is a booster dose of **Td (tetanus-diphtheria)**.
- This ensures continued **protection against tetanus and diphtheria**, as immunity from the primary series may wane over time.
- **Td is preferred over TT** (tetanus toxoid alone) as it provides protection against both tetanus and diphtheria.
- This is administered at **10 years and 16 years** as per the Indian Academy of Pediatrics immunization schedule.
*DPT*
- **DPT (diphtheria, pertussis, tetanus)** is administered in infancy and early childhood (at 6, 10, and 14 weeks, with boosters at 16-24 months and 4-6 years).
- The **pertussis component is not given** in later childhood or adolescence due to increased reactogenicity in older children.
*BCG*
- **BCG (Bacille Calmette-Guérin)** vaccine protects against tuberculosis and is given **at birth** in endemic areas like India.
- It is **not routinely administered** to a 10-year-old unless there are specific risk factors or documented non-vaccination status.
*MMR*
- **MMR (measles, mumps, rubella)** vaccine is given as **two doses**: first at 9-12 months and second at 16-24 months (or 4-6 years).
- A 10-year-old child would have **already completed** their MMR vaccination schedule.
Vaccination in Special Populations Indian Medical PG Question 3: Which vaccine is to be given every year?
- A. Hepatitis A
- B. Chicken pox
- C. Influenza (Correct Answer)
- D. Pneumococcal
Vaccination in Special Populations Explanation: ***Influenza***
- The **influenza virus** undergoes constant **antigenic drift and shift**, leading to new strains emerging each year.
- **Annual vaccination** is necessary to provide protection against the most prevalent strains circulating in a given flu season.
- WHO updates vaccine composition yearly based on global surveillance data.
*Hepatitis A*
- The Hepatitis A vaccine provides **long-term immunity** (potentially lifelong) after completion of the two-dose series.
- It is **not required annually** - typically given at 0 and 6-12 months.
*Chicken pox*
- The **varicella vaccine** provides strong, long-lasting protection against chickenpox after a two-dose series.
- **Annual vaccination is not recommended** - two doses given at appropriate intervals provide adequate immunity.
*Pneumococcal*
- **Pneumococcal vaccines** (PCV13, PPSV23) are given once or at specific intervals based on age and risk factors.
- They do **not require annual administration** in the general population - typically one-time or with specific booster schedules for high-risk groups.
Vaccination in Special Populations Indian Medical PG Question 4: Which vaccine is contraindicated in pregnancy?
- A. Influenza
- B. Rubella (Correct Answer)
- C. Tetanus toxoid
- D. Hepatitis B
Vaccination in Special Populations Explanation: ***Rubella***
- The **rubella vaccine** is a **live attenuated vaccine**, which carries a theoretical risk of fetal infection and congenital rubella syndrome if administered during pregnancy.
- For this reason, women are usually screened for immunity and vaccinated **pre-conception** or **postpartum**.
*Influenza*
- The **influenza vaccine** (inactivated form) is **recommended** during pregnancy to protect both the mother and newborn from severe influenza illness.
- It is **safe** and **effective** for pregnant women at any stage of gestation.
*Tetanus toxoid*
- The **tetanus toxoid vaccine** (Tdap or Td) is **recommended** during each pregnancy to provide passive immunity to the newborn against pertussis (whooping cough), as well as protecting the mother from tetanus and diphtheria.
- It is considered **safe** and ideally given between 27 and 36 weeks of gestation.
*Hepatitis B*
- The **hepatitis B vaccine** is **recommended** for pregnant women who are at high risk of hepatitis B infection, as a protective measure for both the mother and the fetus.
- It is an **inactivated vaccine** and has not been shown to cause adverse effects in pregnancy.
Vaccination in Special Populations Indian Medical PG Question 5: In which of the following disorders, vaccines are not contraindicated in the person suffering from that disease?
- A. Digeorge syndrome
- B. Wiskott Aldrich syndrome
- C. Ataxia telangiectasia
- D. Complement deficiency disorders (Correct Answer)
Vaccination in Special Populations Explanation: ***Complement deficiency disorders***
- While patients with **complement deficiencies** are susceptible to certain infections (especially by encapsulated bacteria), their adaptive immune system is generally intact.
- Therefore, most vaccines, including **live attenuated vaccines**, are not contraindicated; in fact, vaccination is crucial for preventing infections in these patients.
*Digeorge syndrome*
- This syndrome involves **thymic hypoplasia or aplasia**, leading to severe **T-cell immunodeficiency**.
- **Live attenuated vaccines** (e.g., MMR, varicella) are contraindicated due to the risk of uncontrolled replication of the vaccine strain in immunocompromised individuals.
*Wiskott Aldrich syndrome*
- This is an **X-linked immunodeficiency** characterized by immunodeficiency, eczema, and thrombocytopenia, involving defects in both T and B cell function, and **platelet dysfunction**.
- Due to profound immune defects, particularly in T-cell function, **live attenuated vaccines** are contraindicated.
*Ataxia telangiectasia*
- This is an autosomal recessive disorder causing **progressive cerebellar ataxia**, telangiectasias, and severe **combined immunodeficiency (SCID)-like features** affecting both T and B cells, as well as an increased risk of malignancy.
- Due to the severe immunodeficiency, **live attenuated vaccines** are contraindicated.
Vaccination in Special Populations Indian Medical PG Question 6: A child is a known case of HIV with a CD4 count of 50 . Which of the following vaccines should be avoided in this child?
- A. MMR
- B. TT
- C. BCG (Correct Answer)
- D. DPT
- E. OPV
Vaccination in Special Populations Explanation: ***BCG***
- **BCG vaccine** contains live attenuated bacteria and is **absolutely contraindicated** in severely immunocompromised individuals, such as an **HIV-positive child with a CD4 count of 50**, due to the risk of disseminated BCG infection.
- A **CD4 count of 50** indicates severe immunosuppression (AIDS stage), making live vaccines like BCG extremely unsafe.
- **This is the most strongly contraindicated vaccine** in this clinical scenario.
*MMR*
- **MMR (Measles, Mumps, Rubella) vaccine** is a live attenuated vaccine that is generally contraindicated in **severely immunocompromised HIV patients** with **CD4 count <200 cells/µL**.
- With a **CD4 count of 50**, this vaccine would typically be contraindicated due to severe immunosuppression.
- However, **BCG carries a higher risk** of disseminated infection and is more strongly contraindicated.
*OPV*
- **OPV (Oral Polio Vaccine)** is a live attenuated vaccine and is contraindicated in **immunocompromised individuals** including those with severe HIV infection.
- However, most vaccination programs now use **IPV (Inactivated Polio Vaccine)** which is safe for HIV-positive children.
- **BCG remains the most critical contraindication** in severe immunosuppression.
*TT*
- **TT (Tetanus Toxoid)** is an inactivated vaccine containing no live organisms and is **safe for immunocompromised individuals**, including those with HIV.
- Inactivated vaccines are generally recommended for HIV-positive individuals to provide protection against common infections.
*DPT*
- **DPT (Diphtheria, Pertussis, Tetanus)** is an inactivated vaccine and is **safe for immunocompromised children** with HIV.
- It does not pose a risk of infection from the vaccine itself and is crucial for protecting against these severe childhood diseases.
Vaccination in Special Populations Indian Medical PG Question 7: Which vaccine is contraindicated in a baby with uncontrolled epilepsy or progressive neurological disorder?
- A. Rubella
- B. Measles
- C. DPT (Correct Answer)
- D. BCG
Vaccination in Special Populations Explanation: ***DPT***
- The **pertussis component** of the DPT vaccine is contraindicated in children with **uncontrolled epilepsy** or **progressive neurological disorders** as per IAP and WHO guidelines.
- **Absolute contraindications** include: progressive neurological disorder, uncontrolled seizures, and encephalopathy within 7 days of a previous pertussis-containing vaccine dose.
- **Important distinction**: A past history of **resolved febrile seizures** or **controlled epilepsy** is considered a **precaution, not a contraindication**. After stabilization, acellular pertussis vaccine (DTaP) or whole-cell vaccine can be administered.
- The concern is that pertussis vaccine may trigger seizures in children with active, unstable neurological conditions.
*Rubella*
- Rubella vaccine is a **live attenuated vaccine** with no specific contraindication related to neurological disorders or seizure history.
- Adverse effects are typically mild and transient (**fever, rash**) without significant neurological complications.
*Measles*
- The measles vaccine (part of the **MMR vaccine**) is a live attenuated vaccine and is **not contraindicated** in children with a history of seizures or neurological disorders.
- While post-vaccination fever may rarely trigger febrile seizures in susceptible individuals, this is not a contraindication to vaccination.
*BCG*
- The **BCG vaccine** (Bacille Calmette-Guérin) is a live attenuated vaccine used against tuberculosis.
- There are **no contraindications** for BCG vaccination in children with neurological disorders or seizure history.
Vaccination in Special Populations Indian Medical PG Question 8: Who is known as the father of microbiology?
- A. Robert Brown
- B. J.C. Bose
- C. Louis Pasteur
- D. Antonie van Leeuwenhoek (Correct Answer)
Vaccination in Special Populations Explanation: ***Antonie van Leeuwenhoek***
- **Antonie van Leeuwenhoek** is widely recognized for his groundbreaking work in microscopy, which led to the discovery of microorganisms.
- He was the first to observe and accurately describe bacteria, protozoa, and other microscopic life forms, which he called "animalcules," using single-lens microscopes of his own design.
*Robert Brown*
- **Robert Brown** was a Scottish botanist known for his important contributions to botany, including the discovery of the cell nucleus and the description of Brownian motion.
- While significant in biology, his work primarily focused on plant structures and physics, not the direct study of microorganisms.
*J.C. Bose*
- **Jagadish Chandra Bose** was a polymath from British India, a physicist, biologist, botanist, and archaeologist.
- He made pioneering contributions to the investigation of radio and microwave optics, made significant contributions to plant science, and was an early writer of science fiction, but his work was not in microbiology.
*Louis Pasteur*
- **Louis Pasteur** is famous for his discoveries concerning the principles of vaccination, microbial fermentation, and pasteurization.
- While he is a pivotal figure in microbiology, often called the "father of modern microbiology" due to his foundational work on germ theory and disease, Van Leeuwenhoek predates him as the first to observe microorganisms.
Vaccination in Special Populations Indian Medical PG Question 9: All of the following regarding rotavirus vaccine are correct except?
- A. Oral vaccine
- B. Cannot be given after 6 months of age (Correct Answer)
- C. Available as monovalent and pentavalent
- D. Live vaccine
Vaccination in Special Populations Explanation: ***Cannot be given after 6 months of age***
- This statement is **INCORRECT**, making it the correct answer for this "EXCEPT" question.
- The rotavirus vaccine CAN be given after 6 months of age when completing the vaccination series.
- **Rotarix (RV1)**: First dose at 6-14 weeks, second dose by **8 months of age**
- **RotaTeq (RV5)**: First dose at 6-14 weeks, complete 3-dose series by **8 months of age**
- The key restriction is that the **first dose must be given between 6 to 14 weeks 6 days** (not after 15 weeks due to increased intussusception risk), but subsequent doses can be given after 6 months to complete the series.
*Oral vaccine*
- **CORRECT statement**: The rotavirus vaccine is an **oral vaccine**, administered as drops into the infant's mouth.
- This route avoids injections and improves compliance in pediatric immunization.
*Available as monovalent and pentavalent*
- **CORRECT statement**: Two types are available:
- **Rotarix (RV1)**: Monovalent vaccine targeting G1P[8] strain
- **RotaTeq (RV5)**: Pentavalent vaccine targeting G1, G2, G3, G4, and P[8] strains
- Both are highly effective in preventing severe rotavirus gastroenteritis.
*Live vaccine*
- **CORRECT statement**: Both rotavirus vaccines contain **live, attenuated viruses**.
- This stimulates robust mucosal and systemic immunity against rotavirus infection.
- Contraindicated in severe combined immunodeficiency (SCID) and after intussusception.
Vaccination in Special Populations Indian Medical PG Question 10: A young male came to the hospital with a clean-cut wound without any bleeding. The patient received a full course of tetanus vaccination 10 years ago. What is the best management for this patient?
- A. Single-dose tetanus toxoid (Correct Answer)
- B. Human tetanus immunoglobulin only
- C. Human tetanus immunoglobulin and a full course of vaccine
- D. No treatment required
Vaccination in Special Populations Explanation: ***Single-dose tetanus toxoid***
- For a **clean-cut wound** in a patient who completed a **primary tetanus vaccination series** and received their last dose more than 5 years ago but less than 10 years ago, a **single booster dose** of tetanus toxoid is recommended. [1]
- A booster ensures continued protection, as vaccine-induced immunity wanes over time, but the prior full course provides a robust anamnestic response with a single dose.
*Human tetanus immunoglobulin and a full course of vaccine*
- This regimen (tetanus immunoglobulin + vaccine) is typically reserved for patients with **unvaccinated status**, an **unknown vaccination history**, or a **severely contaminated wound** (e.g., rusty nail, soil contamination) who have not been fully vaccinated.
- The patient had a **clean-cut wound** and completed a full course of vaccination 10 years ago, making immunoglobulin unnecessary and a full course of vaccine excessive.
*Human tetanus immunoglobulin only*
- Administering **tetanus immunoglobulin alone** is appropriate for immediate, passive immunity in situations where a patient is unvaccinated or has an unknown vaccination status and has a significant risk of tetanus from a contaminated wound. [2]
- This patient has a clean wound and a history of full vaccination, so a booster is sufficient to stimulate active immunity.
*No treatment required*
- While the patient was fully vaccinated 10 years ago, the protection from tetanus vaccination can **wane over time**, especially after 5-10 years.
- A **booster dose** is crucial to maintain adequate protection against tetanus, even for a clean wound, given the 10-year interval since the last dose.
More Vaccination in Special Populations Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
